Quality of life and treatment of late-stage chronic kidney disease

September 11, 2012

Renal transplantation is best treatment option for improving quality of life in people with late-stage chronic kidney disease

In people with late-stage chronic kidney disease, renal transplantation is the best treatment option to improve quality of life, but for those receiving dialysis, home-based automated peritoneal dialysis (in which fluids are infused into the and can be done nightly at home) provides a better quality of life than continuous ambulatory peritoneal dialysis (a type of dialysis performed continuously throughout the day), according to a study by Australian researchers published in this week's .

The researchers, led by Wyld from the University of Sydney, reviewed and assimilated all of the available published evidence to investigate whether quality of life in people with late-stage chronic kidney disease (as measured by utilities—a numerical value measured on a 0 to 1 scale [where 0 represents death and 1 represents full health] of the strength of an individual's for specified health-related outcomes) differed according to treatment type.

In their analysis, which represented over 56,000 patients, the researchers found that the average utility for those who had a renal transplantation was 0.82, followed by the pre-dialysis group (0.79), patients treated with dialysis (0.70), and finally, patients receiving conservative care (0.62). When comparing the type of dialysis, the researchers found that there was no significant difference in utilities between haemodialysis and peritoneal dialysis, but patients using automated peritoneal dialysis had, on average, a higher utility (0.80) than those treated with continuous ambulatory peritoneal dialysis (0.72).

In addition to helping to inform economic evaluations of treatment options, the information from this analysis can help guide clinicians caring for patients with in their discussions about possible .

The authors conclude: "Our results suggest that automated peritoneal dialysis, a home-based form of dialysis that accounts for just 7% of dialysis patients in the UK and 4% of dialysis patients in the United States, has a significantly higher mean utility than continuous ambulatory peritoneal dialysis."

Commenting on the findings, the authors said: "The finding that transplant patients' utilities increased significantly between the 1980s and the 2000s likely reflects improvements in transplant care and evolving clinical practice."

They add: "We found that patients who chose conservative care had significantly lower than patients treated with dialysis, although the number of studies was small."

Explore further: Snapshot of dialysis: Who's getting treated at home?

More information: Wyld M, Morton RL, Hayen A, Howard K, Webster AC (2012) A Systematic Review and Meta-Analysis of Utility-Based Quality of Life in Chronic Kidney Disease Treatments. PLoS Med 9(9): e1001307. doi:10.1371/journal.pmed.1001307

Related Stories

Snapshot of dialysis: Who's getting treated at home?

February 2, 2012
Home-based dialysis treatments are on the rise in both the developing and developed worlds, but developed countries appear to be turning to them less often, according to a study appearing in an upcoming issue of the Journal ...

Surprising results for use of dialysis for kidney failure in developing world

April 26, 2012
Researchers at Lawson Health Research Institute have discovered that developing countries have faster growing rates of use of home-based dialysis (called peritoneal dialysis) for kidney failure than the developed world. Despite ...

Intensive kidney dialysis indicates better survival rates than conventional dialysis

April 25, 2012
Patients suffering with end-stage renal disease could increase their survival chances by undergoing intensive dialysis at home rather than the conventional dialysis in clinics. A new study by Lawson Health Research Institute ...

Recommended for you

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

Scientists identify biomarkers that indicate likelihood of survival in infected patients

November 17, 2017
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Research team unlocks secrets of Ebola

November 16, 2017
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...

Study raises possibility of naturally acquired immunity against Zika virus

November 16, 2017
Birth defects in babies born infected with Zika virus remain a major health concern. Now, scientists suggest the possibility that some women in high-risk Zika regions may already be protected and not know it.

A structural clue to attacking malaria's 'Achilles heel'

November 16, 2017
Researchers from The Scripps Research Institute (TSRI) and PATH's Malaria Vaccine Initiative (MVI) have shed light on how the human immune system recognizes the malaria parasite though investigation of antibodies generated ...

Molecular pathway offers treatment targets for pulmonary fibrosis, related conditions

November 15, 2017
A study led by investigators at Massachusetts General Hospital (MGH) and University Health Network (UHN) in Toronto has identified a molecular pathway that appears to be critical to the development of fibrosis - scarring ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.